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ABSTRACT
Crystallization from solution and melt is increasingly important method for separation
and purification process in wide varieties of industries such as pharmaceutical
industry. Pharmaceutical crystallization specifically involves drugs of a high degree of
chemical complexity. To date, sugar based-drug cocrystal produced either in melt or
solution involving alpha-lactose monohydrate is yet to be reported. Thus, possibility
of formation of alpha-lactose monohydrate-racemic ibuprofen cocrystal either in
solution or melt is not known. This study is conducted to analyze the formation of
product crystals recovered from PEG 300 solutions containing alpha-lactose
monohydrate, racemic ibuprofen; and the possibility of cocrystal formation of product
crystals from alpha-lactose monohydrate/racemic ibuprofen system in solution via
polyethylene glycol 300 aqueous solution and in melt via physical mixtures. The
objective of this thesis to determine the solid state properties and possible formation
of cocrystals on product crystals grown via trial and error method, melted physical
mixtures and melted granules. Possible crystal morphology and formation of cocrystal
is simulated using molecular modelling.The morphological prediction in vacuum
using suitable force fields and hence surface chemistry of alpha-lactose monohydrate
and racemic ibuprofen was carried out first as preparation for cocrystal prediction.
The cocrystal prediction or binding between alpha-lactose monohydrate and racemic
ibuprofen was checked on its availability of mutual formation of hydrogen bond. The
predicted lattice energy of alpha-lactose monohydrate and racemic ibuprofen was in
agreement with the experimental lattice energy with percentage errors of 3.9 % and
0.02%, respectively. The morphology of alpha-lactose monohydrate is predicted to be
elongated hexagonal, similarly found when alpha-lactose monohydrate was grown in
PEG 300 solutions. However, the predicted morphology of racemic ibuprofen
contradicted with the experimental ones. It was found that the lattice energy of alpha-
lactose monohydrate was dominated by the weak van der Waals force, so did racemic
ibuprofen. All alpha-lactose monohydrate surfaces or facets were tested by modelling
the binding of racemic ibuprofen onto the surfaces. Successful binding prediction of
five facets by surface docking method proved that racemic ibuprofen was capable to
attach to certain facets of alpha-lactose monohydrate. This occurred by alpha-lactose
monohydrate layers accepting hydrogen and oxygen atoms of racemic ibuprofen, thus
forming co-crystal. Results of powder FTIR, DSC and XRD on melted granules,
melted physical mixtures and crystals grown from PEG 300 solutions containing
racemic ibuprofen and alpha-lactose monohydrate, respectively indicated that the
substance was not co-crystal within this scope of experimental study
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